1. Home
  2. CCSI vs CSTL Comparison

CCSI vs CSTL Comparison

Compare CCSI & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

HOLD

Current Price

$37.39

Market Cap

648.0M

Sector

Technology

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$33.05

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCSI
CSTL
Founded
2021
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
648.0M
722.8M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
CCSI
CSTL
Price
$37.39
$33.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$42.25
★ $45.22
AVG Volume (30 Days)
84.7K
★ 319.5K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 2.72
N/A
Revenue
★ $349,696,000.00
$344,229,000.00
Revenue This Year
$3.01
$8.49
Revenue Next Year
$3.66
$10.44
P/E Ratio
$13.58
★ N/A
Revenue Growth
N/A
★ 3.66
52 Week Low
$20.20
$17.72
52 Week High
$41.40
$44.28

Technical Indicators

Market Signals
Indicator
CCSI
CSTL
Relative Strength Index (RSI) 54.95 47.52
Support Level $32.99 $31.44
Resistance Level $38.38 $34.23
Average True Range (ATR) 1.21 1.69
MACD 0.13 -0.13
Stochastic Oscillator 85.71 21.52

Price Performance

Historical Comparison
CCSI
CSTL

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: